TY - JOUR
T1 - Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c
AU - Chen, Yifang
AU - Perry, Daniel
AU - Boackle, Susan A.
AU - Sobel, Eric S.
AU - Molina, Hector
AU - Croker, Byron P.
AU - Morel, Laurence
PY - 2005/7/15
Y1 - 2005/7/15
N2 - The systemic lupus erythematosus 1 (Sle1) locus mediates the loss of tolerance to nuclear Ags in the NZM2410 mouse model of lupus through intrinsic defects in both B and T cells. Congenic analysis has shown that Sle1 corresponds to at least three genetic loci, Sle1a, Sle1b, and Sle1c. Telomeric Sle1c is associated with abnormal B cell responses to subthreshold stimulation with anti-IgM and C3d and with decreased T-dependent humoral immune responses. We have proposed that these phenotypes resulted from polymorphisms in the C3 complement receptor O2 gene. We have also found that Slelc was associated with the production of histone-specific autoreactive CD4+ T cells, which correlated with higher activation and proliferative responses, and a reduction in the CD4+CD25+CD62L+ forkhead/winged helix transcription factor gene (Foxp3+) compartment. In this study we showed, using congenic recombinants, that the decreased humoral immune response and impaired GC formation map to the NZM2410 Cr2 allele. A chronic graft-vs-host disease model also showed that Sle1c produces significantly more autoreactive B cells than B6 controls, and that this phenotype maps to two regions excluding the Cr2 gene. Mixed bone marrow chimera demonstrated that the increased activation, proliferative response, and reduced regulatory T cell compartment were intrinsic to Sle1c-expressing CD4+ T cells. These phenotypes mapped to the same two loci identified with the chronic graft-vs-host disease model, excluding the Cr2 region. Overall, these results show that Sle1c results in the production of autoreactive B and T cells through the expression of three different genes, one of which is consistent with Cr2, based on the phenotypes of the Cr2-deficient mice, and the other two corresponding to as yet unidentified genes.
AB - The systemic lupus erythematosus 1 (Sle1) locus mediates the loss of tolerance to nuclear Ags in the NZM2410 mouse model of lupus through intrinsic defects in both B and T cells. Congenic analysis has shown that Sle1 corresponds to at least three genetic loci, Sle1a, Sle1b, and Sle1c. Telomeric Sle1c is associated with abnormal B cell responses to subthreshold stimulation with anti-IgM and C3d and with decreased T-dependent humoral immune responses. We have proposed that these phenotypes resulted from polymorphisms in the C3 complement receptor O2 gene. We have also found that Slelc was associated with the production of histone-specific autoreactive CD4+ T cells, which correlated with higher activation and proliferative responses, and a reduction in the CD4+CD25+CD62L+ forkhead/winged helix transcription factor gene (Foxp3+) compartment. In this study we showed, using congenic recombinants, that the decreased humoral immune response and impaired GC formation map to the NZM2410 Cr2 allele. A chronic graft-vs-host disease model also showed that Sle1c produces significantly more autoreactive B cells than B6 controls, and that this phenotype maps to two regions excluding the Cr2 gene. Mixed bone marrow chimera demonstrated that the increased activation, proliferative response, and reduced regulatory T cell compartment were intrinsic to Sle1c-expressing CD4+ T cells. These phenotypes mapped to the same two loci identified with the chronic graft-vs-host disease model, excluding the Cr2 region. Overall, these results show that Sle1c results in the production of autoreactive B and T cells through the expression of three different genes, one of which is consistent with Cr2, based on the phenotypes of the Cr2-deficient mice, and the other two corresponding to as yet unidentified genes.
UR - http://www.scopus.com/inward/record.url?scp=23244454763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23244454763&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.175.2.1080
DO - 10.4049/jimmunol.175.2.1080
M3 - Article
C2 - 16002709
AN - SCOPUS:23244454763
SN - 0022-1767
VL - 175
SP - 1080
EP - 1089
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -